GlassScriptPhysician profile
Kamel N Addo
NPI 1700864626
$21,837.40
in general payments reported to CMS, 2019-2025
25 companies · $3,072 in 2025
The $3,072 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,018 · 2020: $339 · 2021: $1,659 · 2022: $1,119 · 2023: $1,448 · 2024: $5,181 · 2025: $3,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,426 · Travel and Lodging: $4,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,426.02 |
| Travel and Lodging | $4,275.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,620.85 | 2019-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Boston Scientific Corporation | $5,500.90 | 2019-2025 | Watchman Flx, Watchman Access System, Emblem Mri S-Icd |
| Medtronic, INC. | $891.93 | 2021-2025 | Micra, Arctic Front Advance, Aurora Ev-Icd Mri Surescan |
| Philips North America LLC | $476.83 | 2019-2024 | (Ao0) Igt Devices Intracardiac, (Ck4) Mcot, (Ck7) Extended Holter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.11 | 2020-2025 | Lifevest |
| Biosense Webster, INC. | $275.73 | 2019-2024 | Carto 3 |
| Pfizer INC. | $247.08 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $194.82 | 2022-2025 | |
| Cardiva Medical, INC. | $163.45 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Astrazeneca Pharmaceuticals LP | $161.75 | 2019-2023 | Farxiga |
| Medtronic Vascular, INC. | $159.29 | 2019 | |
| Shockwave Medical, INC | $130.02 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $122.32 | 2023 | |
| Janssen Pharmaceuticals, INC | $96.38 | 2020-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.87 | 2023-2025 | Jardiance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $91.24 | 2024-2025 | Wegovy, Ozempic |
| Ethicon US, LLC | $62.84 | 2025 | Surgiflo Hemostatic Matrix, Ethicon, Stratafix |
| Biotronik INC. | $52.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $51.19 | 2020-2024 | Camzyos |
| Kestra Medical Technology Services, INC. | $50.75 | 2024 | Assure Wcd |
| Astellas Pharma US INC | $41.02 | 2019 | |
| Impulse Dynamics (USA) INC. | $20.50 | 2024 | Optimizer |
| Amgen INC. | $16.07 | 2024 | |
| Abiomed | $14.26 | 2020 | |
| Altathera Pharmaceuticals LLC | $5.54 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamel Addo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.